搜索优化
English
搜索
图片
Copilot
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
drugdeliverybusiness
2 天
Dexcom inks glucose biosensor partnership with Life Time
Dexcom (Nasdaq:DXCM) announced that it entered into a new partnership with Life Time Inc., an operator of athletic country clubs.
drugdeliverybusiness
2 天
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
drugdeliverybusiness
3 天
Micron Biomedical raises $33M for needle-free drug delivery tech
Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 ...
drugdeliverybusiness
3 天
Analysts say Embecta is ‘heading in the right direction’ following patch pump ...
Analysts called a stock sell-off at Embecta "unwarranted" and believe the company is moving in the right direction despite recent challenges.
drugdeliverybusiness
4 天
Aerosol drug delivery company Aerogen to expand in Ireland
[Image from Aerogen] Aerogen announced today that it plans to invest about $308.5 million (€300 million) to expand operations in Ireland. The company — headquartered in Dangan, Galway — expects its ...
drugdeliverybusiness
5 天
BD increases U.S. syringe, IV catheter manufacturing
BD (NYSE:BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...
drugdeliverybusiness
6 天
Insulet rolls out Omnipod 5 in more European countries
Acton, Massachusetts-based Insulet touts Omnipod 5 as the number one insulin pump for new users in Europe. It remains the top ...
drugdeliverybusiness
6 天
Spirit Health to make new CGM available in UK
Spirit Health said on social media that it plans to make a new continuous glucose monitor (CGM) available next month.
drugdeliverybusiness
7 天
Dexcom expects sales to grow 14% in 2025
Dexcom (Nasdaq:DXCM) today announced preliminary financial results with projections for significant sales growth in 2025.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈